A New Algorithm for Sustainable Testing Capacity in Response to a Pandemic

A peer-reviewed article just published in the Annals of Medicine titled “Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic” describes an algorithm for sustainable testing capacity to efficiently evaluate patients in response to a pandemic.

The multi-tiered, diagnostic strategy incorporates a rapid host immune response assay (such as FebriDx®) as a screening test, molecular confirmatory testing, and rapid IgM/IgG testing (such as COV-ID™) to assess benefit from quarantine/further testing and provide information on population exposure/herd immunity.

May 5, 2021

Lumos Diagnostics Appoints Three Industry Leaders as Independent Directors

Lumos Diagnostics announced today the expansion of its board with the appointment of three new independent directors to support the continued growth of the company’s rapid point-of-care diagnostic products and services business.

Reach out to Lumos today to understand how we can deliver you a customized point-of-care diagnostic solution.